# Fareva and ApiJect sign 10-year licensing deal for BFS production lines

Fareva and ApiJect Systems signed a 10-year licensing agreement to install three Blow-Fill-Seal production lines in France, with Fareva investing over €50 million. The lines will be able to fill-finish more than 500 million doses per year of vaccines and injectable drugs, starting in H2 2022.

- Type: Partnership
- Announced: 2021-12-09
- Where: France, France
- Value: $56.5M (50.0M EUR)
- Status: announced
- Capacity: 500 million doses per year
- Products: vaccines, large molecule injectable drugs, prefilled injectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fareva](https://endata.com/companies/21770.md)
- [ApiJect Systems](https://endata.com/companies/59577.md) (partner)

## Sources

- [pharmaceuticalonline.com](https://www.pharmaceuticalonline.com/doc/fareva-and-apiject-sign-year-licensing-agreement-production-lines-0001), 2021-12-09: "Fareva intends to invest more than €50M (US$ 56.5M) for these three manufacturing lines, with support from the Government of France."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.